Annovis Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANVS research report →
About the company
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases.
- CEO
- Maria L. Maccecchini
- IPO
- 2020
- Employees
- 8
- HQ
- Malvern, PA, US
Price Chart
- Market Cap
- $37.97M
- P/E
- -1.31
- P/S
- 0.00
- P/B
- 17.19
- EV/EBITDA
- -0.58
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -318.08%
- ROIC
- -1199.65%
- Revenue
- $0 · 0.00%
- Net Income
- $-28,854,197 · -17.34%
- EPS
- $-1.40 · 99.93%
- Op Income
- $-29,695,258
- FCF YoY
- -17.01%
- 52W High
- $5.50
- 52W Low
- $1.54
- 50D MA
- $1.95
- 200D MA
- $2.54
- Beta
- 1.19
- Avg Volume
- 1.23M
Get TickerSpark's AI analysis on ANVS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 20, 26 | Hoffman Michael B | buy | 54,933 |
| May 20, 26 | Hoffman Michael B | buy | 18,849 |
| May 20, 26 | Hoffman Michael B | buy | 2,562 |
| Apr 2, 26 | Hoffman Michael B | buy | 713,800 |
| Dec 8, 25 | Hoffman Michael B | buy | 15,000 |
| Dec 8, 25 | Hoffman Michael B | buy | 30,000 |
| Nov 24, 25 | Hoffman Michael B | buy | 28,096 |
| Nov 24, 25 | Hoffman Michael B | buy | 415 |
| Nov 24, 25 | Hoffman Michael B | buy | 9,200 |
| Nov 24, 25 | Hoffman Michael B | buy | 1,489 |
Our ANVS coverage
Recent articles, reports, and earnings notes.
No research on ANVS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ANVS report →Similar companies
Peers in the same neighborhood.